Olaplex (NASDAQ:OLPX) Stock Rating Upgraded by Zacks Research

Olaplex (NASDAQ:OLPX) was upgraded by research analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a research note issued on Tuesday,Zacks.com reports.

OLPX has been the topic of several other reports. Northland Securities assumed coverage on Olaplex in a research report on Thursday, November 20th. They issued an “outperform” rating and a $2.00 price target on the stock. Canaccord Genuity Group raised shares of Olaplex from a “hold” rating to a “buy” rating and upped their target price for the company from $1.50 to $2.00 in a research note on Monday, August 25th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Olaplex in a report on Wednesday, October 8th. Barclays cut their target price on Olaplex from $1.50 to $1.25 and set an “equal weight” rating for the company in a research report on Monday, November 10th. Finally, Telsey Advisory Group reiterated a “market perform” rating and issued a $2.00 price target on shares of Olaplex in a research report on Friday, November 7th. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $1.85.

Olaplex Price Performance

Shares of NASDAQ:OLPX opened at $1.12 on Tuesday. The stock has a market capitalization of $747.61 million, a P/E ratio of 55.00 and a beta of 2.29. The business has a 50-day moving average of $1.18 and a two-hundred day moving average of $1.33. Olaplex has a fifty-two week low of $0.99 and a fifty-two week high of $2.28. The company has a debt-to-equity ratio of 0.40, a current ratio of 4.16 and a quick ratio of 3.52.

Olaplex (NASDAQ:OLPX) last issued its quarterly earnings data on Thursday, November 6th. The company reported $0.02 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.02. The business had revenue of $114.58 million for the quarter, compared to the consensus estimate of $109.77 million. Olaplex had a positive return on equity of 1.31% and a negative net margin of 1.18%.The firm’s revenue was down 3.8% compared to the same quarter last year. During the same period last year, the business earned $0.04 EPS. Olaplex has set its FY 2025 guidance at EPS. On average, equities research analysts predict that Olaplex will post 0.1 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the business. T. Rowe Price Investment Management Inc. grew its holdings in Olaplex by 12.5% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 27,567,214 shares of the company’s stock worth $35,011,000 after acquiring an additional 3,066,614 shares during the last quarter. Portolan Capital Management LLC increased its stake in shares of Olaplex by 132.6% in the 3rd quarter. Portolan Capital Management LLC now owns 3,635,124 shares of the company’s stock valued at $4,762,000 after buying an additional 2,072,383 shares during the period. Ninety One UK Ltd boosted its holdings in Olaplex by 1.6% in the third quarter. Ninety One UK Ltd now owns 3,385,918 shares of the company’s stock valued at $4,436,000 after acquiring an additional 52,863 shares during the last quarter. Bridgeway Capital Management LLC raised its holdings in Olaplex by 2.1% during the 3rd quarter. Bridgeway Capital Management LLC now owns 2,684,791 shares of the company’s stock worth $3,517,000 after purchasing an additional 55,652 shares during the last quarter. Finally, Balyasny Asset Management L.P. raised its stake in shares of Olaplex by 1,314.1% during the second quarter. Balyasny Asset Management L.P. now owns 1,508,013 shares of the company’s stock worth $2,111,000 after buying an additional 1,401,369 shares during the last quarter. 87.37% of the stock is owned by institutional investors.

About Olaplex

Olaplex Holdings, Inc develops, manufactures, and sells hair care products in the United States and internationally. The company offers hair care shampoos and conditioners for use in treatment, maintenance, and protection of hair, as well as oil, moisture mask, and nourishing hair serum. It provides hair care products to professional hair salons, retailers, and everyday consumers.